Request Your Free White Paper Now:

"eConsent: Flexible Consent Through Enabling Technologies"

YPrime experts discuss why the industry remains divided on the value of eConsent and how technology can enable a more flexible way to approach the informed consent process.

Although the life science industry has been exploring the use of digital technologies to simplify the informed consent process, COVID-19 proved to be an inflection point for the industry to implement digital technologies in earnest. The eClinical technology industry has benefitted by implementing design techniques and user-centric approaches gleaned from consumer-oriented industries to overcome historic objections. Yet, the industry remains divided on the value of creating a digital consent solution—the informed consent process is either too simple to invest money in, or too complicated for an effective technology solution. In this article, YPrime experts discuss:

• Perceptions of eConsent and why industry has been hesitant to adopt it
• How the goals of eConsent align with traditional approaches to informed consent while improving patient comprehension
• How eConsent enables a more flexible approach to the informed consent process

Offered Free by: YPrime
See All Resources from: YPrime